Does OLAPARIB Cause Pneumonitis? 124 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 124 reports of Pneumonitis have been filed in association with OLAPARIB (Lynparza). This represents 0.7% of all adverse event reports for OLAPARIB.
124
Reports of Pneumonitis with OLAPARIB
0.7%
of all OLAPARIB reports
22
Deaths
55
Hospitalizations
How Dangerous Is Pneumonitis From OLAPARIB?
Of the 124 reports, 22 (17.7%) resulted in death, 55 (44.4%) required hospitalization, and 7 (5.6%) were considered life-threatening.
Is Pneumonitis Listed in the Official Label?
Yes, Pneumonitis is listed as a known adverse reaction in the official FDA drug label for OLAPARIB.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Pneumonitis?
NIVOLUMAB (2,076)
PEMBROLIZUMAB (1,933)
METHOTREXATE (1,188)
PACLITAXEL (1,110)
CARBOPLATIN (975)
EVEROLIMUS (919)
IPILIMUMAB (891)
ATEZOLIZUMAB (842)
DURVALUMAB (827)
RITUXIMAB (747)
Which OLAPARIB Alternatives Have Lower Pneumonitis Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL